The Pharmaceutical Inspection Co-operation Scheme (PIC/S) this week revised its good manufacturing practice (GMP) guide (PE 009-16) to reflect the new EU clinical trials regulation (CTR), which took ...

The EU’s pending revision of Annex 1 covering good manufacturing practice (GMP) for sterile drug products is a “significant improvement” over the previous version and emphasizes the importance of risk ...

Dublin, April 10, 2026 (GLOBE NEWSWIRE)-- The "New EU GMP Annex 1: Compliant Sterile Medicinal Products (May 19th - May 23rd, 2026)" training has been added to ResearchAndMarkets.com's offering. The ...

The Hemas Group is in the process of obtaining EU GMP (European Union Good Manufacturing Practice), in a bid to venture into European markets with their locally-made medicines, a top official said.

The "New EU (European Union) GMP (Good Manufacturing Practice) Annex 1: Compliant Aseptic Operations Training Course (May 19th - May 21st, 2026)" training has been added to ResearchAndMarkets.com's ...

EDMONTON, AB, July 14, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce that its dedicated ...

Annex 21 is sometimes viewed as a narrow regulatory annex, but its implications are much broader. It sits at the intersection ...

Largest producer of medicinal cannabis in Africa to grow exports in Germany as well as enter UK, Poland, and other countries following EU-GMP Certification EU-GMP Certification is a huge milestone for ...

HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is ...

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.